Ascend Wellness Holdings, Inc.
Historical Data
View all| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 3, 2026 | $186.32 | $190.59 | $173.54 | $180.15 | 3.39M |
| Jul 2, 2026 | $195.53 | $198.53 | $184.55 | $186.32 | 2.17M |
| Jul 1, 2026 | $198.47 | $201.27 | $193.39 | $195.53 | 3.05M |
| Jun 30, 2026 | $201.72 | $205.58 | $195.37 | $198.47 | 3.87M |
| Jun 29, 2026 | $203.62 | $209.80 | $198.56 | $201.72 | 2.87M |
| Jun 28, 2026 | $209.90 | $217.71 | $201.41 | $203.62 | 2.69M |
| Jun 27, 2026 | $215.18 | $221.51 | $200.68 | $209.90 | 2.74M |
| Jun 26, 2026 | $207.63 | $220.93 | $197.57 | $215.18 | 2.00M |
Company Overview
Ascend Wellness Holdings, Inc. operates in the healthcare space within the Healthcare sector. The company generates the majority of its revenue from operating momentum, and has built a durable competitive position through scale, brand, and continued reinvestment. It serves customers globally and is headquartered in the United States. Reported figures on this page are generated for demonstration and are not investment advice.
Leadership
Board 12 · Independent 11 of 12| Date | Firm | Target | Rating |
|---|---|---|---|
| Jun 29 | Mizuho | $262.30 | Neutral |
| Jun 26 | Needham | $197.34 | Hold |
| Jun 12 | JPMorgan | $259.11 | Strong Buy |
| May 26 | JPMorgan | $179.74 | Reduce |
| May 25 | Citi | $200.30 | Hold |
| May 21 | BofA Securities | $311.47 | Overweight |
Politician Trades
View allWhat's Happening Right Now
- Aug 31, 2026 · Corporate Action ↗ — AAWH stockholders approved a board-controlled reverse stock split, a prerequisite step toward a planned U.S. exchange listing.
- Aug 12, 2026 · Earnings ↗ — Ascend Wellness reported a Q2 loss but beat revenue estimates.
- Feb 13, 2026 · Legal ↗ — Ascend Wellness paid $17M to resolve an arbitration award related to a GTI dispute.
- May 13, 2026 · Earnings ↗ — AWH reported its first quarter 2026 financial results.
- Jun 25, 2026 · Governance ↗ — Shareholders approved a bylaw revision lowering the quorum requirement.
Snapshot
In FY2025, Ascend Wellness generated $500.58M in revenue, down 10.9% year-over-year, with a gross margin of 33.9%. The company posted an operating loss of $17.01M and a larger net loss of $80.90M, reflecting costs beyond core operations. Despite the losses, operating cash flow was positive at $38.05M, and after $26.01M in capital expenditures, free cash flow remained positive at $12.04M. The balance sheet shows $85.68M in cash against $244.91M in total debt.
Bottom Line
Ascend Wellness combines a shrinking top line and persistent net losses with genuine positive operating and free cash flow, a somewhat unusual combination in the cannabis sector that suggests underlying operational discipline despite revenue pressure. The debt load ($244.91M) well exceeds cash on hand ($85.68M), and the pending reverse split and U.S. uplisting effort add corporate-action uncertainty and dilution risk for investors weighing the cash generation against balance sheet leverage.